AQR Capital Management LLC

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
13,314
Total Value
97069812583
Accession Number
0001085146-25-003311
Form Type
13F-HR
CIK
0001167557
Manager Name
AQR Capital Management LLC
Data Enrichment
96% identified
12,822 identified492 unidentified

Holdings

13,314 positions
Manager:
SEC
Search and click to pin securities to the top
Page 148 of 158
CRAWFORD & CO
CRD-A|224633206
Shares:
13138
Value:
$150.0M
Taysha Gene Therapies, Inc.
TSHA|877619106
Shares:
107899(+325.6%)
Value:
$150.0M(+241.9%)
PUMA BIOTECHNOLOGY, INC.
PBYI|74587V107
Shares:
50458(+366.5%)
Value:
$149.4M(+352.7%)
LINDBLAD EXPEDITIONS HOLDINGS, INC.
LIND|535219109
Shares:
15994(+44.4%)
Value:
$148.3M(+12.9%)
Adverum Biotechnologies, Inc.
ADVM|00773U207
Shares:
33823
Value:
$147.8M
Aeva Technologies, Inc.
AEVA|00835Q202
Shares:
20849(+29.1%)
Value:
$145.9M(+90.3%)
FIRST ADVANTAGE CORP
FA|31846B108
Shares:
10353(-3.4%)
Value:
$145.9M(-27.3%)
PureCycle Technologies, Inc.
PCT|74623V103
Shares:
20963(+67.9%)
Value:
$145.1M(+13.3%)
NI Holdings, Inc.
NODK|65342T106
Shares:
10035
Value:
$143.1M
Pulmonx Corp
LUNG|745848101
Shares:
21196(-25.1%)
Value:
$142.6M(-25.7%)
Aveanna Healthcare Holdings, Inc.
AVAH|05356F105
Shares:
26280(+21.2%)
Value:
$142.4M(+43.8%)
Annexon, Inc.
ANNX|03589W102
Shares:
73790(+122.6%)
Value:
$142.4M(-16.3%)
ARS Pharmaceuticals, Inc.
SPRY|82835W108
Shares:
11116
Value:
$139.8M
TEMPLETON EMERGING MARKETS FUND
EMF|880191101
Shares:
10866
Value:
$139.6M
Absci Corp
ABSI|00091E109
Shares:
55538(+279.4%)
Value:
$139.4M(+263.5%)
Nurix Therapeutics, Inc.
NRIX|67080M103
Shares:
11668(-83.5%)
Value:
$138.6M(-89.6%)
Kyverna Therapeutics, Inc.
KYTX|501976104
Shares:
71057
Value:
$137.1M
02217A102
02217A102
Shares:
27167
Value:
$134.5M
Ramaco Resources, Inc.
METC|75134P600
Shares:
16339(-67.7%)
Value:
$134.5M(-74.1%)
ImmunityBio, Inc.
IBRX|45256X103
Shares:
44448(+193.4%)
Value:
$133.8M(+244.9%)